Hi-Clearance Inc. (TPEX:1788)

Market Cap	5.77B -7.2%
Revenue (ttm)	4.41B +5.2%
Net Income	391.96M +11.5%
EPS	8.80 +11.5%
Shares Out	44.52M
PE Ratio	14.72
Forward PE	n/a
Dividend	7.00 (5.36%)
Ex-Dividend Date	Jun 16, 2026

Volume	12,567
Open	129.50
Previous Close	130.50
Day's Range	129.50 - 129.50
52-Week Range	129.00 - 139.50
Beta	0.10
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 24, 2026

About Hi-Clearance

Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dentistry, oral surgery, thoracic, respiratory, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and, RO machines, and related consumables and drugs; interventional cardiology and radiology, and plastic surgery devices; dentistry consumables, implant materials, and equipment; and blood glucose monitors, and related consumables and nutrition products, as well as hemodialysis management services. It engages in the design and management of dialysi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1989
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1788

Financial Performance

In 2025, Hi-Clearance's revenue was 4.28 billion, an increase of 5.04% compared to the previous year's 4.07 billion. Earnings were 368.51 million, an increase of 2.45%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 19, 2026

Data Sources Report a data error